US Stock MarketDetailed Quotes

SeaStar Medical (ICU)

Watchlist
  • 3.810
  • -0.320-7.75%
Close Apr 27 16:00 ET
15.22MMarket Cap-0.65P/E (TTM)

SeaStar Medical (ICU) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
814.07%1.23M
526.87%420K
169.12%183K
338K
293K
135K
67K
68K
0
0
Operating revenue
814.07%1.23M
526.87%420K
169.12%183K
--338K
--293K
--135K
--67K
--68K
--0
--0
Cost of revenue
53K
12K
14K
27K
0
0
0
0
0
0
Gross profit
774.81%1.18M
508.96%408K
148.53%169K
311K
293K
135K
67K
68K
0
0
Operating expense
-25.71%13.36M
-29.17%3.42M
-17.15%3.75M
-55.73%2.07M
4.18%4.12M
26.51%17.98M
64.59%4.83M
53.77%4.52M
24.51%4.67M
-13.77%3.95M
Selling and administrative expenses
-34.20%5.84M
-41.60%1.22M
-13.25%1.9M
-55.89%1.03M
-25.26%1.68M
7.71%8.87M
18.96%2.1M
17.95%2.19M
32.00%2.34M
-20.98%2.25M
-General and administrative expense
-34.20%5.84M
-41.60%1.22M
-13.25%1.9M
-55.89%1.03M
-25.26%1.68M
7.71%8.87M
18.96%2.1M
17.95%2.19M
32.00%2.34M
-20.98%2.25M
Research and development costs
-17.43%7.52M
-19.65%2.2M
-20.80%1.85M
-55.57%1.04M
43.25%2.43M
52.44%9.11M
133.02%2.74M
114.90%2.34M
17.82%2.33M
-1.91%1.7M
Operating profit
31.76%-12.18M
36.73%-3.02M
19.68%-3.58M
62.39%-1.76M
3.24%-3.82M
-25.56%-17.84M
-62.31%-4.77M
-51.46%-4.46M
-24.51%-4.67M
13.77%-3.95M
Net non-operating interest income expense
97.20%-4K
-58.82%112K
150.00%107K
-359.65%-262K
125.87%37K
86.77%-143K
236.68%272K
4.46%-214K
74.67%-57K
66.97%-143K
Non-operating interest income
221.78%325K
557.89%125K
84.48%107K
80.00%45K
--48K
--101K
--19K
--58K
--25K
--0
Non-operating interest expense
-87.30%31K
105.14%13K
--0
-89.02%9K
-92.31%11K
-77.43%244K
-227.14%-253K
21.43%272K
-63.56%82K
-66.97%143K
Total other finance cost
--298K
--0
----
--298K
----
----
----
----
----
----
Other net income (expense)
100.47%32K
0
-98.93%16K
100.19%16K
37.46%-6.84M
101.20%76K
104.72%192K
-2.61%1.49M
-313.26%-8.6M
Gain on sale of security
104.59%32K
--0
----
-99.15%16K
100.19%16K
8.65%-697K
106.13%76K
-81.27%192K
15.13%1.88M
-313.26%-8.6M
Special income (charges)
----
----
----
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
----
----
----
----
----
-17.52%-6.15M
--0
----
-287.00%-387K
----
Income before tax
51.07%-12.15M
34.28%-2.9M
22.47%-3.47M
38.08%-2M
70.32%-3.77M
5.36%-24.83M
53.30%-4.42M
38.08%-4.48M
-32.39%-3.23M
-78.93%-12.7M
Income tax
0.00%3K
0
0
0
3K
3K
0
0
-40.00%3K
0
Net income
51.07%-12.15M
34.28%-2.9M
22.47%-3.47M
38.13%-2M
70.29%-3.77M
5.34%-24.83M
53.27%-4.42M
38.08%-4.48M
-32.24%-3.24M
-78.93%-12.7M
Net income continuous Operations
51.07%-12.15M
34.28%-2.9M
22.47%-3.47M
38.13%-2M
70.29%-3.77M
5.34%-24.83M
53.27%-4.42M
38.08%-4.48M
-32.24%-3.24M
-78.93%-12.7M
Minority interest income
Net income attributable to the parent company
51.07%-12.15M
34.28%-2.9M
22.47%-3.47M
38.13%-2M
70.29%-3.77M
5.34%-24.83M
53.27%-4.42M
38.08%-4.48M
-32.24%-3.24M
-78.93%-12.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
51.07%-12.15M
34.28%-2.9M
22.47%-3.47M
38.13%-2M
70.29%-3.77M
5.34%-24.83M
53.27%-4.42M
38.08%-4.48M
-32.24%-3.24M
-78.93%-12.7M
Basic earnings per share
91.17%-5.86
91.11%-0.8
88.18%-1.3
82.52%-1.8
90.70%-4.4
78.08%-66.33
81.87%-9
87.80%-11
74.88%-10.3
64.96%-47.3
Diluted earnings per share
91.17%-5.86
91.11%-0.8
88.18%-1.3
82.52%-1.8
90.70%-4.4
78.08%-66.33
81.87%-9
87.80%-11
74.88%-10.3
64.96%-47.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 814.07%1.23M526.87%420K169.12%183K338K293K135K67K68K00
Operating revenue 814.07%1.23M526.87%420K169.12%183K--338K--293K--135K--67K--68K--0--0
Cost of revenue 53K12K14K27K000000
Gross profit 774.81%1.18M508.96%408K148.53%169K311K293K135K67K68K00
Operating expense -25.71%13.36M-29.17%3.42M-17.15%3.75M-55.73%2.07M4.18%4.12M26.51%17.98M64.59%4.83M53.77%4.52M24.51%4.67M-13.77%3.95M
Selling and administrative expenses -34.20%5.84M-41.60%1.22M-13.25%1.9M-55.89%1.03M-25.26%1.68M7.71%8.87M18.96%2.1M17.95%2.19M32.00%2.34M-20.98%2.25M
-General and administrative expense -34.20%5.84M-41.60%1.22M-13.25%1.9M-55.89%1.03M-25.26%1.68M7.71%8.87M18.96%2.1M17.95%2.19M32.00%2.34M-20.98%2.25M
Research and development costs -17.43%7.52M-19.65%2.2M-20.80%1.85M-55.57%1.04M43.25%2.43M52.44%9.11M133.02%2.74M114.90%2.34M17.82%2.33M-1.91%1.7M
Operating profit 31.76%-12.18M36.73%-3.02M19.68%-3.58M62.39%-1.76M3.24%-3.82M-25.56%-17.84M-62.31%-4.77M-51.46%-4.46M-24.51%-4.67M13.77%-3.95M
Net non-operating interest income expense 97.20%-4K-58.82%112K150.00%107K-359.65%-262K125.87%37K86.77%-143K236.68%272K4.46%-214K74.67%-57K66.97%-143K
Non-operating interest income 221.78%325K557.89%125K84.48%107K80.00%45K--48K--101K--19K--58K--25K--0
Non-operating interest expense -87.30%31K105.14%13K--0-89.02%9K-92.31%11K-77.43%244K-227.14%-253K21.43%272K-63.56%82K-66.97%143K
Total other finance cost --298K--0------298K------------------------
Other net income (expense) 100.47%32K0-98.93%16K100.19%16K37.46%-6.84M101.20%76K104.72%192K-2.61%1.49M-313.26%-8.6M
Gain on sale of security 104.59%32K--0-----99.15%16K100.19%16K8.65%-697K106.13%76K-81.27%192K15.13%1.88M-313.26%-8.6M
Special income (charges) ----------------------0--0--0--------
Other non- operating income (expenses) ---------------------17.52%-6.15M--0-----287.00%-387K----
Income before tax 51.07%-12.15M34.28%-2.9M22.47%-3.47M38.08%-2M70.32%-3.77M5.36%-24.83M53.30%-4.42M38.08%-4.48M-32.39%-3.23M-78.93%-12.7M
Income tax 0.00%3K0003K3K00-40.00%3K0
Net income 51.07%-12.15M34.28%-2.9M22.47%-3.47M38.13%-2M70.29%-3.77M5.34%-24.83M53.27%-4.42M38.08%-4.48M-32.24%-3.24M-78.93%-12.7M
Net income continuous Operations 51.07%-12.15M34.28%-2.9M22.47%-3.47M38.13%-2M70.29%-3.77M5.34%-24.83M53.27%-4.42M38.08%-4.48M-32.24%-3.24M-78.93%-12.7M
Minority interest income
Net income attributable to the parent company 51.07%-12.15M34.28%-2.9M22.47%-3.47M38.13%-2M70.29%-3.77M5.34%-24.83M53.27%-4.42M38.08%-4.48M-32.24%-3.24M-78.93%-12.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 51.07%-12.15M34.28%-2.9M22.47%-3.47M38.13%-2M70.29%-3.77M5.34%-24.83M53.27%-4.42M38.08%-4.48M-32.24%-3.24M-78.93%-12.7M
Basic earnings per share 91.17%-5.8691.11%-0.888.18%-1.382.52%-1.890.70%-4.478.08%-66.3381.87%-987.80%-1174.88%-10.364.96%-47.3
Diluted earnings per share 91.17%-5.8691.11%-0.888.18%-1.382.52%-1.890.70%-4.478.08%-66.3381.87%-987.80%-1174.88%-10.364.96%-47.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i Show More